<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:43:05Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14406" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/14406</identifier><datestamp>2026-10-18T20:29:12Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Letter to the Editor on “Serum and Wound Vancomycin Levels Following Intrawound Administration in Primary Total Joint Arthroplasty”</dc:title><dc:creator>Duman, Serda</dc:creator><dc:creator>Sofu, Hakan</dc:creator><dc:creator>Çamurcu, İsmet Y.</dc:creator><dc:subject>Anti-Bacterial Agents</dc:subject><dc:subject>Arthroplasty</dc:subject><dc:subject>Humans</dc:subject><dc:subject>Surgical Wound Infection</dc:subject><dc:subject>Vancomycin</dc:subject><dc:subject>tranexamic acid</dc:subject><dc:subject>antiinfective agent</dc:subject><dc:subject>allergic reaction</dc:subject><dc:subject>drug blood level</dc:subject><dc:subject>drug tissue level</dc:subject><dc:subject>drug use</dc:subject><dc:subject>human</dc:subject><dc:subject>infection prevention</dc:subject><dc:subject>Letter</dc:subject><dc:subject>postoperative infection</dc:subject><dc:subject>reperfusion</dc:subject><dc:subject>total knee arthroplasty</dc:subject><dc:subject>wound</dc:subject><dc:subject>surgical infection</dc:subject><dc:publisher>Churchill Livingstone Inc.</dc:publisher><dc:date>2018</dc:date><dc:type>Letter</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/14406</dc:identifier><dc:identifier>https://doi.org/10.1016/j.arth.2017.11.005</dc:identifier><dc:identifier>0883-5403</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Arthroplasty</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/14406</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>